⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Azepane SCHEMBL31538612 | 0.97 | ALDH1A1 (0.60) | — | |
| Piperidine SCHEMBL1627913 | 0.97 | — | — | |
| Piperidine SCHEMBL31756943 | 0.94 | ALDH1A1 (0.56) | — | |
| Piperidine SCHEMBL28211779 | 0.94 | ALDH1A1 (0.56) | — | |
| Azetidine SCHEMBL10008124 | 0.93 | — | — | |
| Azetidine SCHEMBL28206632 | 0.89 | — | — | |
| Aziridine SCHEMBL27622900 | 0.89 | — | — | |
| Pyrrolidine SCHEMBL27855624 | 0.88 | ALDH1A1 (0.42) | — | |
| Piperidine SCHEMBL15510479 | 0.86 | ALDH1A1 (0.47) | — | |
| Piperazine SCHEMBL5875159 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250362278-A1 | MASS SPECTROMETRY OF MRNA | MODERNATX, INC. (US) | 2025-11-27 | — | — | US | claimed |
| CN-119080615-A | Method for preparing long-chain dibasic acid or dibasic ester | 中国科学院大连化学物理研究所 | 2024-12-06 | — | — | CN | claimed |
| EP-4426853-A1 | MASS SPECTROMETRY OF MRNA | ModernaTX, Inc. (US) | 2024-09-11 | — | — | EP | claimed |
| WO-2023076658-A1 | MASS SPECTROMETRY OF MRNA | MODERNATX, INC. (US) | 2023-05-04 | — | — | WO | claimed |
| US-11506581-B2 | Mass spectrometry compatible salt formation for ionic liquid sample preparation | AGILENT TECHNOLOGIES, INC. (US) | 2022-11-22 | — | — | US | claimed |
| CN-114702506-A | 11-carbonyl-20-ethoxy economic oridonin and 14-OH esterified series derivatives and application thereof | 郑州大学 | 2022-07-05 | — | — | CN | claimed |
| CN-108084446-B | Pyrrolizine molecular imprinting material, preparation method and application thereof | 北京工商大学 | 2021-03-05 | — | — | CN | claimed |
| US-20190293530-A1 | MASS SPECTROMETRY COMPATIBLE SALT FORMATION FOR IONIC LIQUID SAMPLE PREPARATION | AGILENT TECHNOLOGIES, INC. | 2019-09-26 | — | — | US | claimed |
| EP-3543704-A1 | MASS SPECTROMETRY COMPATIBLE SALT FORMATION FOR IONIC LIQUID SAMPLE PREPARATION | Agilent Technologies, Inc. (US) | 2019-09-25 | — | — | EP | claimed |
| US-8124766-B2 | Inhibitors of diacylglycerol acyltransferase | MADRIGAL PHARMACEUTICALS, INC. (US) | 2012-02-28 | — | — | US | claimed |
| EP-2367817-A1 | INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE | Via Pharmaceuticals, Inc. (US) | 2011-09-28 | — | — | EP | claimed |
| WO-2010065310-A1 | INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE | VIA PHARMACEUTICALS, INC (US) | 2010-06-10 | — | — | WO | claimed |
| US-20100145047-A1 | INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE | MADRIGAL PHARMACEUTICALS, INC. | 2010-06-10 | — | — | US | claimed |
| US-20250362278-A1 | MASS SPECTROMETRY OF MRNA | MODERNATX, INC. (US) | 2025-11-27 | — | — | US | disclosed |
| US-20250242275-A1 | APPARATUS AND METHOD FOR PROCESSING A BIOMASS MATERIAL | BUSS-SMS-CANZLER GMBH (DE) | 2025-07-31 | — | — | US | disclosed |
| US-20250145889-A1 | METHOD FOR PROCESSING A BIOMASS MATERIAL | PROIONIC GMBH (AT) | 2025-05-08 | — | — | US | disclosed |
| US-8124766-B2 | Inhibitors of diacylglycerol acyltransferase | MADRIGAL PHARMACEUTICALS, INC. (US) | 2012-02-28 | — | — | US | disclosed |
| EP-2367817-A1 | INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE | Via Pharmaceuticals, Inc. (US) | 2011-09-28 | — | — | EP | disclosed |
| WO-2010065310-A1 | INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE | VIA PHARMACEUTICALS, INC (US) | 2010-06-10 | — | — | WO | disclosed |
| US-20100145047-A1 | INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE | MADRIGAL PHARMACEUTICALS, INC. | 2010-06-10 | — | — | US | disclosed |